NEW YORK, April 24 –Buoyed by sales of seven new MassArray genotyping systems, Sequenom reported a substantial spike in first-quarter 2001 revenues Tuesday, while losses narrowed and beat expectations.

"Milestones and growth achieved during the first quarter have bolstered both our genomics  and systems businesses, and we are aggressively expanding our leadership position in the market," said Toni Schuh, Sequenom’s CEO, in a statement. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.